Medgenics Inc Purchase of Common Stock by Chairman (6102V)
16 Diciembre 2013 - 8:00AM
UK Regulatory
TIDMMEDG TIDMMEDU
RNS Number : 6102V
Medgenics Inc
16 December 2013
Press Release 16 December 2013
Medgenics Reports Open Market Purchase of Common Stock by
Chairman of the Board
Medgenics, Inc. (AIM: MEDU, MEDG and NYSE MKT: MDGN), ("the
Company"), the developer of Biopump(TM) , a novel technology for
the sustained production and delivery of therapeutic proteins in
patients using their own tissue, announces that on December 13,
2013, the Company was informed by Dr. Sol Barer, Medgenics'
Chairman of the Board, that he purchased 20,000 shares of common
stock on the open market on that day at an average price of $5.3711
per share.
Following this purchase, Dr. Barer now owns 112,000 shares of
common stock, which represents approximately 0.6 per cent of the
total issued shares of common stock. Dr. Barer, directly or through
trusts for the benefit of Dr. Barer and his family, also has the
right to purchase up to 1,315,000 shares of common stock pursuant
to options previously granted (in aggregate Dr. Barer's shares of
common stock and options represent 1,427,000 shares of common stock
which represent approximately 7.7 per cent of the Company's total
issued shares of common stock).
This announcement is being made pursuant to the London Stock
Exchange's AIM Rules for Companies admitted to trading on the AIM
market.
About Medgenics
Medgenics is developing and commercializing Biopump(TM), a
proprietary tissue-based platform technology for the sustained
production and delivery of therapeutic proteins using the patient's
own tissue for the treatment of a range of chronic diseases
including anemia, hepatitis, among others. For more information,
please visit www.medgenics.com.
Contacts:
Medgenics, Inc.
John Leaman, CFO
john.leaman@medgenics.com
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
@LHA_IR_PR
Abchurch Communications
Joanne Shears / Jamie Hooper
/ Harriet Rae
harriet.rae@abchurch-group.com +44 207 398 7718
Oriel Securities (NOMAD & Broker)
Jonathan Senior / Giles Balleny +44 207 710 7617
-Ends-
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAEAKFEKDFFF
Medgenics(Regs) (LSE:MEDG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Medgenics(Regs) (LSE:MEDG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024